Harmony Biosciences Holdings, Inc. HRMY
32.47 USD -1.95 (-5.65%)
At closeNov 5, 2026, 4:00 PM EST
32.47 0.00 0.00%
After hours · Nov 5, 4:00 PM ET
32.31 Day range 35.68
25.90 52-week range 43.49
- YTD
- -13.23%
- 1 year
- +3.57%
Financial health
Altman Z-Score
5.02 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
6 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
A+4 / 5 overall
- DCF 5
- Return on Equity 4
- Return on Assets 5
- Debt / Equity 4
- P/E 3
- P/B 3
Valuation
P/E 13.6×
FY 2018 5y median 14.9× FY 2025
P/S 2.5×
FY 2018 5y median 3.3× FY 2025
P/B 2.5×
FY 2018 5y median 4.1× FY 2025
P/FCF 6.2×
FY 2018 5y median 9.0× FY 2025
EV/EBITDA 6.4×
FY 2018 5y median 8.1× FY 2025
EV/Sales 1.9×
FY 2018 5y median 3.1× FY 2025
FCF Yield 16.2%
FY 2018 5y median 11.2% FY 2025
Profitability
Gross Margin 77.2%
FY 2018 5y median 79.2% FY 2025
Operating Margin 24.0%
FY 2018 5y median 27.4% FY 2025
Net Margin 18.3%
FY 2018 5y median 20.4% FY 2025
ROE 18.2%
FY 2018 5y median 22.1% FY 2025
ROIC 13.9%
FY 2018 5y median 20.1% FY 2025
ROA 12.5%
FY 2018 5y median 14.6% FY 2025
Growth (YoY)
Revenue 21.5%
FY 2018 FY 2025
Operating Income 9.2%
FY 2018 FY 2025
EPS (diluted) 8.0%
FY 2018 FY 2025
Free Cash Flow 59.1%
FY 2018 FY 2025
Financial Health
Current Ratio 3.6×
FY 2018 5y median 3.6× FY 2025
Quick Ratio 3.6×
FY 2018 5y median 3.6× FY 2025
Debt / Equity 0.3×
FY 2018 5y median 0.4× FY 2025
Net Debt / EBITDA -2.0×
FY 2018 5y median -0.5× FY 2025
Interest Coverage 14.2×
FY 2018 5y median 8.1× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31